Medeiros M, Velásquez-Jones L

Idioma: Español
Referencias bibliográficas: 26
Paginas: 393-395
Archivo PDF: 38.21 Kb.

FRAGMENTO

La hipertensión arterial ha sido reconocida desde hace mucho tiempo como un factor importante de riesgo cardiovascular.
En los adultos la definición de hipertensión arterial se ha basado en el valor de corte que marca un incremento en los eventos cardiovasculares y la muerte; se ha definido este valor de corte como ≥ 140 mm Hg para la presión sistólica y ≥ 90 mm Hg para la diastólica.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.

2. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-76.

3. Jackson LV, Thalange NK, Cole TJ. Blood pressure centiles for Great Britain. Arch Dis Child 2007; 92: 298-303.

4. Munkhaugen J, Lydersen S, Wideroe TE, Hallan S. Blood pressure reference values in adolescents: methodological aspects and suggestions for Northern Europe tables based on the Nord-Trondelag Health Study II. J Hypertens 2008; 26: 1912-8.

5. Sung RY, Choi KC, So HK, Nelson EA, Li AM, Kwok CW et al. Oscillometrically measured blood pressure in Hong Kong Chinese children and associations with anthropometric parameters. J Hypertens 2008; 26: 678-84.

6. Mitsnefes MM. Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol 2008; 23: 27-39.

7. Annual Report. NAPRTCS 2008; acceso 25 de abril 2010. Disponible en: https://web.emmes.com/study/ped/annlrept/annlrept.html

8. Flynn JT. Hypertension and future cardiovascular disease in pediatric renal transplant recipients. Pediatr Transplant 2006; 10: 276-8.

9. Hadtstein C, Schaefer F. Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 2008; 23: 363-71.

10. Seeman T. Hypertension after renal transplantation. Pediatr Nephrol 2009; 24: 959-72.

11. Cook LG, Chiasson VL, Long C, Wu GY, Mitchell BM. Tacrolimus reduces nitric oxide synthase function by binding to FKBP rather than by its calcineurin effect. Kidney Int 2009; 75: 719-26.

12. Lamas S. Cellular mechanisms of vascular injury mediated by calcineurin inhibitors. Kidney Int 2005; 68: 898-907.

13. Mitsnefes MM. Hypertension and end-organ damage in pediatric renal transplantation. Pediatr Transplant 2004; 8: 394-9.

14. Sorof JM, Goldstein SL, Brewer ED, Steiger HM, Portman RJ. Use of anti-hypertensive medications and post-transplant renal allograft function in children. Pediatr Transplant 2000; 4: 21-7.

15. Silverstein DM, LeBlanc P, Hempe JM, Ramcharan T, Boudreaux JP. Tracking of blood pressure and its impact on graft function in pediatric renal transplant patients. Pediatr Transplant 2007; 11: 860-7.

16. Mitsnefes MM, Omoloja A, McEnery PT. Short-term pediatric renal transplant survival: blood pressure and allograft function. Pediatr Transplant 2001; 5: 160-5.

17. Ramírez-Cortés G, Fuentes-Velasco Y, García-Roca P, Guadarrama O, López M, Valverde-Rosas S, et al. Prevalence of metabolic syndrome and obesity in renal transplanted Mexican children. Pediatr Transplant 2009; 13: 579-84.

18. Wilson AC, Greenbaum LA, Barletta GM, Chand D, Lin JJ, Patel HP, et al. High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients. Pediatr Transplant 2010; 14: 52-60.

19. Fletcher JT, Nankivell BJ, Alexander SI. Chronic allograft nephropathy. Pediatr Nephrol 2009; 24: 1465-71.

20. Mitsnefes MM, Portman RJ. Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant 2003; 7: 86-92.

21. McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, et al. Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr Transplant 2006; 10: 558-64.

22. Ferraris JR, Ghezzi L, Waisman G, Krmar RT. ABPM vs. office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplant 2007; 11: 24-30.

23. Kitzmueller E, Vecsei A, Pichler J, Bohm M, Muller T, Vargha R, et al. Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol 2004; 19: 1385-9.

24. Seeman T, Simkova E, Kreisinger J, Vondrak K, Dusek J, Gilik J, et al. Control of hypertension in children after renal transplantation. Pediatr Transplant 2006; 10: 316-22.

25. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2009; 77: 299-311.

26. Krmar RT, Berg UB. Blood pressure control in hypertensive pediatric renal transplants: role of repeated ABPM following transplantation. Am J Hypertens 2008; 21: 1093-9.